Risk assessment

7th Sep 2026

Published in PharmaTimes magazine -
Early digital diagnostics are transforming liver care

Chronic liver disease is a silent, global epidemic. But as metabolic conditions continue to rise, integrating digital diagnostics into routine blood work is unlocking the power of early, proactive intervention, shifting the healthcare paradigm from reactive treatment to lifelong prevention.

Liver disease is no longer a niche health issue. It is a growing public health challenge affecting an estimated 1.5 billion people worldwide and placing increasing pressure on healthcare systems.

Yet despite advances in our understanding of disease risk and progression, too many patients are still being diagnosed only after significant and often irreversible liver damage has already occurred.

Check out the rest of the feature here

PharmaTimes Magazine

Tags